A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant increase in ...

Cendes explains that in Parkinson's disease, there are changes in the brain structure of the so-called basal ganglia – areas of the brain associated with automatic movement. However, the study ...

Parkinson's disease, a degenerative brain condition primarily marked by the loss of muscle control, has been thrust into the media over the years in film and television. But there's still a ton of ...

Parkinson's disease (PD) has been a widely known debilitative neurodegenerative condition affecting millions of people worldwide. While it's often mistakenly assumed to be a fatal illness, Parkinson's ...

In the very earliest stages of Parkinson’s, one of the most common symptoms is REM sleep behaviour disorder, in which the person acts out their dreams during sleep, often through movements or sounds.

Data from Phase IIb PADOVA study and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class ...

Parkinson's disease (PD) is not a fatal disease, but it can indirectly reduce life expectancy, most often due to complications like aspiration pneumonia or falls. Many factors can influence survival ...